Cargando…

Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia

Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Fei, Ye, Yuanxin, Yin, Dandan, Qin, Yun, Zhao, Jiangyan, Zhang, Wanhua, Zhang, Yan, Deng, Zhujun, Wang, Yuelan, Ying, Binwu, Wang, Lanlan, Gao, Ju, Shu, Yang, Zhu, Yiping, Lu, Xiaoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477633/
https://www.ncbi.nlm.nih.gov/pubmed/33193587
http://dx.doi.org/10.3389/fgene.2020.01004
_version_ 1783579942731120640
author Liao, Fei
Ye, Yuanxin
Yin, Dandan
Qin, Yun
Zhao, Jiangyan
Zhang, Wanhua
Zhang, Yan
Deng, Zhujun
Wang, Yuelan
Ying, Binwu
Wang, Lanlan
Gao, Ju
Shu, Yang
Zhu, Yiping
Lu, Xiaoxi
author_facet Liao, Fei
Ye, Yuanxin
Yin, Dandan
Qin, Yun
Zhao, Jiangyan
Zhang, Wanhua
Zhang, Yan
Deng, Zhujun
Wang, Yuelan
Ying, Binwu
Wang, Lanlan
Gao, Ju
Shu, Yang
Zhu, Yiping
Lu, Xiaoxi
author_sort Liao, Fei
collection PubMed
description Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication study to in all-age Chinese patients (N = 451), not only validating the novel ERG locus, but also systematically determining the impact of age on association status of the top GWAS signals. We found that single nucleotide polymorphisms at ARID5B, IKZF1, CEBPE, PIP4K2A were only significantly associated with ALL susceptibility in childhood patients with no BCR-ABL fusion, while GATA3 signal exhibited its significance in adults no matter carrying BCR-ABL fusion or not. Moreover, the novel ERG SNP can be validated in pediatric patients without both BCR-ABL and ETV6-RUNX1 fusion. Our finding suggests the modifying effects of age on genetic predisposition to ALL, and highlights the impact of ERG SNP in Chinese patients.
format Online
Article
Text
id pubmed-7477633
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74776332020-11-12 Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia Liao, Fei Ye, Yuanxin Yin, Dandan Qin, Yun Zhao, Jiangyan Zhang, Wanhua Zhang, Yan Deng, Zhujun Wang, Yuelan Ying, Binwu Wang, Lanlan Gao, Ju Shu, Yang Zhu, Yiping Lu, Xiaoxi Front Genet Genetics Through genome-wide association studies (GWAS), multiple inherited predispositions to acute lymphoblastic leukemia (ALL) have been identified in children. Most recently, a novel susceptibility locus at ERG was localized, exhibiting Hispanic-specific manner. In this study, we conducted a replication study to in all-age Chinese patients (N = 451), not only validating the novel ERG locus, but also systematically determining the impact of age on association status of the top GWAS signals. We found that single nucleotide polymorphisms at ARID5B, IKZF1, CEBPE, PIP4K2A were only significantly associated with ALL susceptibility in childhood patients with no BCR-ABL fusion, while GATA3 signal exhibited its significance in adults no matter carrying BCR-ABL fusion or not. Moreover, the novel ERG SNP can be validated in pediatric patients without both BCR-ABL and ETV6-RUNX1 fusion. Our finding suggests the modifying effects of age on genetic predisposition to ALL, and highlights the impact of ERG SNP in Chinese patients. Frontiers Media S.A. 2020-08-25 /pmc/articles/PMC7477633/ /pubmed/33193587 http://dx.doi.org/10.3389/fgene.2020.01004 Text en Copyright © 2020 Liao, Ye, Yin, Qin, Zhao, Zhang, Zhang, Deng, Wang, Ying, Wang, Gao, Shu, Zhu and Lu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Liao, Fei
Ye, Yuanxin
Yin, Dandan
Qin, Yun
Zhao, Jiangyan
Zhang, Wanhua
Zhang, Yan
Deng, Zhujun
Wang, Yuelan
Ying, Binwu
Wang, Lanlan
Gao, Ju
Shu, Yang
Zhu, Yiping
Lu, Xiaoxi
Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title_full Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title_fullStr Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title_full_unstemmed Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title_short Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia
title_sort validations of top and novel susceptibility variants in all-age chinese patients with acute lymphoblastic leukemia
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477633/
https://www.ncbi.nlm.nih.gov/pubmed/33193587
http://dx.doi.org/10.3389/fgene.2020.01004
work_keys_str_mv AT liaofei validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT yeyuanxin validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT yindandan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT qinyun validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT zhaojiangyan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT zhangwanhua validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT zhangyan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT dengzhujun validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT wangyuelan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT yingbinwu validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT wanglanlan validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT gaoju validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT shuyang validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT zhuyiping validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia
AT luxiaoxi validationsoftopandnovelsusceptibilityvariantsinallagechinesepatientswithacutelymphoblasticleukemia